Primary Care Research Unit, The Alamedilla Health Center
Salamanca, Castilla and Leon, 37003, Spain
NCT Number: NCT03164499
This is a randomized controlled trial aimed to design an intensive intervention to modify lifestyles of subjects with intermediate cardiovascular risk and evaluate its effectiveness. 200 participants aged 35-74 years who have intermediate cardiovascular risk will be included. Subjects will be selected by consecutive sampling at urban primary care health centers from Salamanca (Spain) and they will be randomized to a control or an intervention group. Both groups will receive individual standardized counselling on healthy diet, daily physical activity, smoking cessation, and moderation in alcohol consumption. Moreover, individuals from the intervention group will receive additional group counselling and follow-up calls. The effect of the intervention will be assessed using lifestyles and quality of life questionnaires, metabolic control parameters, inflammation markers, anthropometric and vascular function measurements, and neuropsychological tests.
Looking for future studies?
Notify Me35 year–74 year
All sexes
Interventional
Not applicable
Salamanca, Castilla and Leon, 37003, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Individual standardized counselling on healthy diet, daily physical activity, stress management, smoking cessation, and moderation in alcohol consumption.
Group sessions focusing on cardiovascular risk, diet and moderation in alcohol consumption, physical activity and stress management, and smoking cessation will be held in health centres for four consecutive weeks. Each session will last 60-90 minutes, and will be led by two trained nurse practitioners. Ten participants will assist each group. During each session, attendance will be recorded and printed educational materials related to the topic addressed will be distributed.
Follow-up calls to reinforce lifestyle modification and record the barriers to behaviour change found will be performed 6 and 9 months after enrolment.
Time frame: 1 year
Measurement by validated 14-point Mediterranean Diet Adherence Screener
Time frame: 1 year
Measurement by short version of the International Physical Activity Questionnaire
Time frame: 1 year
Measurement by Pedometer
Time frame: 1 year
Measurement by semi-quantitative Food Frequency Questionnaire
Time frame: 1 year
Measurement by Framingham Risk Score
Time frame: 1 year
Measurement by Bioelectrical Impedance Analyzer
Time frame: 1 year
Measurement by Vasera® VS-2000 device
Time frame: 1 year
Measurement by Vasera® VS-2000 device
Time frame: 1 year
Measurement by Vasera® VS-2000 device
Time frame: 1 year
Measurement by Spanish version of the SF-12 questionnaire
Time frame: 1 year
Assessment by immediate recall of a list of 15 words, in three attempts
Time frame: 1 year
Assessment by free recall of the words learnt in the first part of the study after a period of approximately 10 minutes
Time frame: 1 year
Assessment by enumerating for one minute as many words as possible starting with different letters
Time frame: 1 year
Assessment by Trail Making Test A
Time frame: 1 year
Assessment by Trail Making Test B
Time frame: 1 year
Assessment by Trail Making Test B
Time frame: 1 year
Assessment by WAIS Digit Span Backward test
Time frame: 1 year
Assessment by Stroop test
Time frame: 1 year
Assessment by Stroop test
Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Other
Effectiveness of an Intensive Intervention to Improve Lifestyles in Subjects With Intermediate Cardiovascular Risk: a Randomized Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04743856
Behavior, Blood Pressure
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT03898206
Behavior, Cardiovascular Diseases
Bedford, Bedfordshire, United Kingdom
View Trial DetailsNCT04645875
Behavior, Cardiovascular Diseases
Bedford, United Kingdom
View Trial DetailsNCT04820933
Cardiovascular Diseases, Cardiovascular Risk Factor
Dallas, Texas, United States
View Trial Details